
Hebei
300255.SZHebei Changshan Biochemical Pharmaceutical Co., Ltd. Price (300255.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
918,674,780
(0.042)%Income Statement Summary
Revenue | |
Cost of Revenue | |
Gross Profit | |
Operating Expenses | |
Operating Income | |
Other Expenses | |
Net Income |


Income Statement
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.Currency: CNY
YEAR | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
110,840,402.00
+0% |
253,753,457.00
+129% |
466,717,967.00
+84% |
423,479,330.00
-9% |
575,558,108.00
+36% |
704,542,401.00
+22% |
811,284,570.00
+15% |
915,987,229.00
+13% |
1,118,414,431.00
+22% |
1,420,161,448.00
+27% |
1,652,633,921.00
+16% |
2,071,479,809.00
+25% |
2,363,785,855.00
+14% |
2,968,050,842.00
+26% |
2,336,229,838.00
-21% |
1,410,439,649.00
-40% |
|||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 77,106,665.00 | 177,901,687.00 | 341,899,929.00 | 282,179,829.00 | 291,709,009.00 | 310,144,404.00 | 335,200,716.00 | 304,119,268.00 | 394,904,385.00 | 490,096,003.00 | 472,248,905.00 | 557,354,349.00 | 740,653,317.00 | 1,241,217,692.00 | 1,298,450,320.00 | 1,733,212,786.00 | |||
Gross Profit | |||||||||||||||||||
Gross Profit |
33,733,737.00
+0% |
75,851,770.00
+125% |
124,818,038.00
+65% |
141,299,501.00
+13% |
283,849,099.00
+101% |
394,397,997.00
+39% |
476,083,854.00
+21% |
611,867,961.00
+29% |
723,510,046.00
+18% |
930,065,445.00
+29% |
1,180,385,016.00
+27% |
1,514,125,460.00
+28% |
1,623,132,538.00
+7% |
1,726,833,150.00
+6% |
1,037,779,518.00
-40% |
-322,773,137.00
-131% |
|||
Gross Profit Ratio | (0.30%) | (0.30%) | (0.27%) | (0.33%) | (0.49%) | (0.56%) | (0.59%) | (0.67%) | (0.65%) | (0.65%) | (0.71%) | (0.73%) | (0.69%) | (0.58%) | (0.44%) | (-0.23%) | |||
Operating Expenses | |||||||||||||||||||
Research and Development | 4,531,309.00 | 7,888,964.00 | 16,068,150.00 | 13,342,082.00 | 17,833,333.00 | 24,738,126.00 | 32,458,054.00 | 32,856,959.00 | 55,134,932.00 | 75,921,713.00 | 98,887,103.00 | 135,911,581.00 | 127,543,413.00 | 150,626,662.00 | 145,014,172.00 | 158,824,447.00 | |||
General and Administrative | 2,703,712.00 | 4,974,906.00 | 9,974,805.00 | 14,180,854.00 | 19,489,262.00 | 35,954,912.00 | 25,763,952.00 | 30,457,431.00 | 28,856,398.00 | 34,073,428.00 | 41,188,169.00 | 59,776,365.00 | 62,364,527.00 | 60,804,528.00 | 58,082,110.00 | 81,725,403.00 | |||
Selling, General & Admin... | 7,628,414.00 | 12,988,062.00 | 20,865,026.00 | 25,128,388.00 | 134,476,730.00 | 194,622,840.00 | 234,844,754.00 | 329,581,576.00 | 396,707,459.00 | 536,984,772.00 | 738,234,068.00 | 1,002,217,033.00 | 1,045,922,699.00 | 1,153,322,266.00 | 671,682,102.00 | 524,438,180.00 | |||
Selling & Marketing Exp... | 4,924,701.00 | 8,013,155.00 | 10,890,221.00 | 10,947,534.00 | 114,987,468.00 | 158,667,928.00 | 209,080,801.00 | 299,124,144.00 | 367,851,060.00 | 502,911,344.00 | 697,045,898.00 | 942,440,668.00 | 983,558,171.00 | 1,092,517,738.00 | 613,599,991.00 | 442,712,777.00 | |||
Depreciation and Amortiz... | 4,334,928.00 | 4,871,028.00 | 5,361,198.00 | 6,236,811.00 | 11,910,352.00 | 17,382,018.00 | 27,877,513.00 | 31,889,071.00 | 36,922,863.00 | 42,118,525.00 | 45,549,184.00 | 52,291,977.00 | 55,280,681.00 | 55,800,777.00 | 56,935,659.00 | 74,701,799.00 | |||
Other Expenses | 685,446.00 | -479,116.93 | 2,238,546.00 | 5,837,292.00 | 5,582,143.00 | 2,498,437.00 | 9,384,769.00 | 11,941,402.00 | 6,135,613.00 | 2,728,096.00 | -1,271,769.24 | -1,241,537.28 | -7,639,683.15 | -1,589,582.26 | -2,336,235.87 | 98,643,157.00 | |||
Total Operating Expenses | 15,296,898.00 | 24,706,863.00 | 44,512,274.00 | 49,972,600.00 | 172,516,284.00 | 248,486,745.00 | 304,363,594.00 | 407,916,010.00 | 497,328,538.00 | 665,481,625.00 | 892,421,841.00 | 1,197,337,023.00 | 1,241,639,380.00 | 1,389,445,667.00 | 902,094,729.00 | 903,551,741.00 | |||
Cost and Exponses | 92,403,563.00 | 202,608,550.00 | 386,412,203.00 | 332,152,430.00 | 464,225,293.00 | 558,631,150.00 | 639,564,311.00 | 712,035,279.00 | 892,232,924.00 | 1,155,577,629.00 | 1,364,670,747.00 | 1,754,691,372.00 | 1,982,292,697.00 | 2,630,663,360.00 | 2,200,545,050.00 | 2,636,764,527.00 | |||
Operating Income | |||||||||||||||||||
Operating Income |
11,077,051.00
+0% |
43,178,987.00
+290% |
67,440,585.00
+56% |
76,769,905.00
+14% |
106,095,917.00
+38% |
132,253,788.00
+25% |
147,488,544.00
+12% |
174,267,985.00
+18% |
198,865,592.00
+14% |
235,560,409.00
+18% |
172,685,595.00
-27% |
262,403,439.00
+52% |
309,196,815.00
+18% |
261,999,184.00
-15% |
20,452,541.00
-92% |
-1,226,324,879.00
-6,096% |
|||
Operating Income Ratio | (0.10%) | (0.17%) | (0.14%) | (0.18%) | (0.18%) | (0.19%) | (0.18%) | (0.19%) | (0.18%) | (0.17%) | (0.10%) | (0.13%) | (0.13%) | (0.09%) | (0.01%) | (-0.87%) | |||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 30,228.00 | 87,538.00 | 103,675.00 | 4,324,701.00 | 11,525,514.00 | 6,505,800.00 | 1,309,820.00 | 890,765.00 | 1,980,229.00 | 5,782,296.00 | 5,535,775.00 | 4,009,749.00 | 1,639,623.00 | 1,303,400.00 | 1,993,819.00 | 1,841,254.00 | |||
Interest Expenses | 6,877,101.00 | 6,045,668.00 | 8,750,329.00 | 12,367,727.00 | 13,533,477.00 | 16,952,902.00 | 26,531,657.00 | 31,965,535.00 | 28,477,300.00 | 30,505,212.00 | 41,984,068.00 | 46,593,488.00 | 55,805,661.00 | 62,294,855.00 | 93,043,168.00 | 99,539,755.00 | |||
Total Other Income/Exp... | -6,506,737.00 | -8,537,936.00 | -9,897,318.00 | -8,281,749.00 | 5,564,246.00 | 2,498,437.00 | 9,381,045.00 | 11,897,351.00 | -21,475,843.00 | 2,728,096.00 | -1,271,764.00 | -1,241,538.00 | -7,639,684.00 | -1,589,583.00 | -2,336,236.00 | -5,369,907.00 | |||
EBITDA | |||||||||||||||||||
EBITDA | 22,974,528.00 | 53,616,567.00 | 83,790,661.00 | 101,250,038.00 | 137,142,290.00 | 169,087,146.00 | 211,278,759.00 | 250,019,943.00 | 269,573,465.00 | 310,912,243.00 | 258,947,079.00 | 360,047,368.00 | 412,643,474.00 | 378,505,234.00 | 168,095,133.00 | -1,056,767,113.00 | |||
EBITDA ratio | (0.21%) | (0.22%) | (0.18%) | (0.24%) | (0.24%) | (0.24%) | (0.26%) | (0.27%) | (0.24%) | (0.22%) | (0.20%) | (0.18%) | (0.18%) | (0.13%) | (0.08%) | (-0.75%) | |||
Income Before Tax | |||||||||||||||||||
Income Before Tax | 11,762,498.00 | 42,699,870.00 | 69,679,132.00 | 82,607,198.00 | 111,660,163.00 | 134,752,225.00 | 156,869,589.00 | 186,165,336.00 | 204,173,301.00 | 238,288,505.00 | 171,413,826.00 | 261,161,901.00 | 301,557,131.00 | 260,409,601.00 | 18,116,305.00 | -1,231,694,786.00 | |||
Income Before Tax Ratio | (0.11%) | (0.17%) | (0.15%) | (0.20%) | (0.19%) | (0.19%) | (0.19%) | (0.20%) | (0.18%) | (0.17%) | (0.10%) | (0.13%) | (0.13%) | (0.09%) | (0.01%) | (-0.87%) | |||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | 2,479,228.00 | 6,334,383.00 | 9,488,605.00 | 11,807,542.00 | 12,665,374.00 | 19,534,163.00 | 22,552,395.00 | 29,491,470.00 | 25,858,043.00 | 35,976,091.00 | 39,202,273.00 | 38,734,091.00 | 50,416,613.00 | 29,148,068.00 | 7,960,208.00 | 16,459,329.00 | |||
Net Income | |||||||||||||||||||
Net Income | 9,283,269.00
+0% |
36,365,486.00
+292% |
60,190,526.00
+66% |
70,799,656.00
+18% |
99,088,101.00
+40% |
115,182,918.00
+16% |
133,732,534.00
+16% |
156,297,275.00
+17% |
175,487,223.00
+12% |
196,919,210.00
+12% |
139,987,092.00
-29% |
225,285,377.00
+61% |
252,842,315.00
+12% |
233,573,840.00
-8% |
17,513,464.00
-93% |
-1,240,210,953.00
-7,181% |
|||
Net Income Ratio | (0.08%) | (0.14%) | (0.13%) | (0.17%) | (0.17%) | (0.16%) | (0.16%) | (0.17%) | (0.16%) | (0.14%) | (0.08%) | (0.11%) | (0.11%) | (0.08%) | (0.01%) | (-0.88%) | |||
Earning Per Share | |||||||||||||||||||
Basic EPS | 0.02 | 0.06 | 0.10 | 0.10 | 0.12 | 0.14 | 0.16 | 0.18 | 0.20 | 0.21 | 0.15 | 0.24 | 0.28 | 0.25 | 0.02 | -1.35 | |||
Diluted EPS | 0.02 | 0.06 | 0.10 | 0.10 | 0.12 | 0.14 | 0.16 | 0.18 | 0.20 | 0.21 | 0.15 | 0.24 | 0.28 | 0.25 | 0.02 | -1.35 | |||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 507,264,386.00 | 567,746,888.00 | 622,239,905.00 | 692,605,333.00 | 825,734,176.00 | 849,710,055.00 | 859,709,150.00 | 847,883,471.00 | 877,436,116.00 | 934,966,878.00 | 933,247,282.00 | 934,966,878.00 | 919,060,878.00 | 919,060,878.00 | 919,060,878.00 | 918,674,780.00 | |||
Diluted Share Outstanding | 507,264,386.00 | 567,746,888.00 | 622,239,905.00 | 692,605,333.00 | 825,734,176.00 | 849,710,055.00 | 859,709,150.00 | 868,318,196.00 | 877,436,116.00 | 937,710,526.00 | 933,247,282.00 | 934,966,878.00 | 919,060,878.00 | 919,060,878.00 | 919,060,878.00 | 918,674,780.00 |